Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03239340
Title A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Osimertinib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Research Site Athens Georgia 30607 United States Details
Research Site Atlanta Georgia 30307 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Brescia 25100 Italy Details
Research Site Meldola 47014 Italy Details
Research Site Monza 20900 Italy Details
Research Site Parma 43126 Italy Details
Research Site Roma 00152 Italy Details
Research Site Terni 05100 Italy Details
Research Site Busan 47392 Korea, Republic of Details
Research Site Cheongiu 28644 Korea, Republic of Details
Research Site Seongnam 13620 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06591 Korea, Republic of Details
Research Site Seoul 135-710 Korea, Republic of Details
Research Site Johor Bahru 81100 Malaysia Details
Research Site Kuantan 25100 Malaysia Details
Research Site Kuching 93586 Malaysia Details
Research Site Lembah Pantai 59100 Malaysia Details
Research Site Pulau Pinang 10450 Malaysia Details
Research Site A Coruña 15006 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Las Palmas de Gran Canaria 35016 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Sevilla 41009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field